Description
This assay uses the Luminex® 200™ platform.
Attention Clinicians! Our Long COVID Vascular Health 18-Plex Panel is now available for clinical diagnostics under CLIA regulation as a Laboratory Developed Test (LDT). This panel includes two simultaneous assays (HDAGP17 and HDSAA6) to assess vascular and endothelial integrity, coagulation, and inflammation—key aspects of long COVID. Running both assays together ensures efficient, high-quality results with a rapid turnaround. For details and to enhance your diagnostic capabilities, visit our patient diagnostics webpage. Reference intervals are available for PLASMA-EDTA samples.
Consider this assay for an extensive analysis of key factors involved in angiogenesis and growth regulation. The Human Angiogenesis & Growth Factor 17-Plex Discovery Assay® Array (HDAGP17) simultaneously measures Angiopoietin-2, BMP-9, EGF, Endoglin, Endothelin-1, FGF-1, FGF-2, Follistatin, G-CSF, HB-EGF, HGF, IL-8, Leptin, PLGF, VEGF-A, VEGF-C, and VEGF-D.
This panel is ideal for exploring the complex interplay of growth factors and cytokines involved in vascular development, tissue repair, and disease states such as cancer and cardiovascular disorders. By evaluating these biomarkers, you can gain insights into processes like angiogenesis, inflammation, and cell proliferation.
Ideal for studying cancer progression, wound healing, and cardiovascular diseases, this assay provides insights into the roles of factors like VEGF-A and FGF-2 in angiogenesis and tissue regeneration. For instance, VEGF-A is crucial for new blood vessel formation, while FGF-2 promotes cell proliferation.
This assay offers a comprehensive tool for understanding the molecular mechanisms underlying pathological conditions and therapeutic responses.
Discover the power of precision with our assay, expertly designed for the Luminex® 200™ platform. This cutting-edge technology enables the simultaneous detection of multiple biomarkers from a minimal single sample, delivering comprehensive insights with unmatched efficiency. Streamline your research and unlock a new level of detail with our advanced multiplex assay solution.
Click here for information on shipping biological samples for Discovery Assays
Published Research Featuring Our HDAGP17:
- Logan, S. M., & Storey, K. B. (2019). Angiogenic signaling in the lungs of a metabolically suppressed hibernating mammal (Ictidomys tridecemlineatus). PeerJ, 7, e8116.
- Nguyen, K. T., Hecking, J., Berg, I. C., Kannappan, R., Donoghue, L., Ismail, E., Cheng, X., Giridharan, G. A., & Sethu, P. (2023). von Willebrand Factor and Angiopoietin-2 are sensitive biomarkers of pulsatility in continuous-flow ventricular assist device patients. ASAIO Journal, 69(6), 569-575.
- Haglund, T. A., Rajasekaran, N. S., Smood, B., Giridharan, G. A., Hoopes, C. W., Holman, W. L., Mauchley, D. C., Prabhu, S. D., Pamboukian, S. V., Tallaj, J. A., Rajapreyar, I. N., Kirklin, J. K., & Sethu, P. (2019). Evaluation of flow-modulation approaches in ventricular assist devices using an in-vitro endothelial cell culture model. The Journal of Heart and Lung Transplantation, 38(4), 456-465.
- Nguyen, K. T., Donoghue, L., Giridharan, G. A., Naber, J. P., Vincent, D., Fukamachi, K., Kotru, A., & Sethu, P. (2022). Acute response of human aortic endothelial cells to loss of pulsatility as seen during cardiopulmonary bypass. Cells Tissues Organs, 211(3), 324–334.